Effect of rhIL-2 in inhalant form on experimental respiratory tract infection with Klebsiella pneumoniae in mice

Yaoxue Xuebao

Volumn 40, Issue 1, 2005, Pages 17-21

  Tang, Yue ^a   Zhu, Jia Bi ^a   Cheng, Du Sheng ^b   Zhang, Xü Song ^a   Zhou, Bo ^a   Shen, Hai Yan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Beijing Sihuan Biological Pharmaceutical Company   (China)

Author keywords

Infection; Inhalant; Klebsiella pneumoniae; Recombinant human interleukin 2

Indexed keywords

INTERLEUKIN 2; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CHEMISTRY; ENTEROBACTER INFECTION; FEMALE; INHALATIONAL DRUG ADMINISTRATION; INSTITUTE FOR CANCER RESEARCH MOUSE; KLEBSIELLA PNEUMONIAE; LUNG; LUNG LAVAGE; METABOLISM; MOUSE; PATHOLOGY;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; INTERLEUKIN-2; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MICE; MICE, INBRED ICR; RECOMBINANT PROTEINS;

EID: 33644686237     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lu JH, Zhang YH, Zhao K. Medical Biological [M]. Beijing: People's Medical Publishing House, 1995. 900-914.
2. Hamm H, Bruggemann M, Frischen M, et al. Tolerance and effects of inhaled recombinant interleukin-2 (rIL-2): a clinical study [J]. Eur Respir J, 1994,7(Suppl 18): 205.
3. Skubitz KM, Anderson PM. Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial [J]. Anti Cancer Drugs, 2000,11(7):555-563.
4. Huland E, Heinzer H, Mir TS, et al. Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience [J]. Cancer J Sci Am, 1997,3(Suppl 1):98-105.
5. Lorenz J, Wilhelm K, Kessler M, et al. Phase I trial of inhaled natural interleukin-2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects [J]. Clin Cancer Res, 1996,2(7):1115-1122.
6. Iizawa Y, Nishi T, Kondo M, et al. Effect of recombinant human interleukin-2 on the course of experiment chronic respiratory tract infection caused by Klebsiella pneumoniae in mice [J]. Infect Immun, 1988, 56(1):45-50.
7. Stephenson EH, Moeller RB, York CG, et al. Nose-only versus whole-body aerosol exposure for induction of upper respiratory infection of laboratory mice [J]. Am Ind Hyg Assoc J, 1988,49(3):128-135.
8. 2 of arterial plasma and BAL in pulmonary edema rats [J]. Chin Pharmacol Bull, 2000, 16 (4):436-438.
9. Sedmak JJ, Grossberg SE. A rapid sensitive and versatile assay for protein using Coomassie Brilliant Blue G250 [J]. Anal Biochem, 1977,79(2):544-552.
10. Duly EB, Grimason S. Measurement of serum albumin by capillary zone electrophoresis, bromocresol green, bromocresol purple, and immunoassay methods [J]. J Clin Pathol, 2003,56(10):780-781.
11. Wang JZ. Para-nitrophenyl phosphate and 2, 4-dinitrobenzene hydrazine method [A]. The second hospital of Hunan medical college. Clinical Biochemistry Examination [M]. 2nd Ed. Changsha: Hunan Science and Technology Press, 1981. 227-228.
12. Benfield TL. Alveolar damage in AIDS-related pneumocystis carinii pneumonia [J]. Chest, 1997,111 (5):1193-1199.